Management of Recurring Keloids
For recurring keloids, surgical excision combined with postoperative intralesional triamcinolone injections is the most effective approach, with postoperative brachytherapy offering the lowest recurrence rates (3.1-15%) for patients who can access radiation therapy.
Treatment Algorithm for Recurring Keloids
First-Line Approach: Surgery + Postoperative Steroids
Surgical excision with postoperative intralesional corticosteroid injections is superior to pre-operative or intra-operative injection timing 1. This combination addresses the aggressive nature of recurrent keloids while minimizing recurrence risk.
Specific Protocol:
- Complete surgical excision of the keloid and its core
- Begin triamcinolone acetonide injections (40 mg/mL) within one week after suture removal
- Continue injections every 2 weeks for 4-6 sessions 2
- Postoperative injection timing reduces recurrence significantly compared to intra-operative (p < 0.001) or pre-operative injection (p = 0.009) 1
Enhanced Multimodal Protocol
For particularly aggressive or large recurrent keloids, combine surgical excision with both pharmacological and physical adjuvant therapies 3, 4:
Triple therapy approach:
- Surgical excision with tension-adapted layered closure
- Intralesional injections: triamcinolone (40 mg/mL) + 5-fluorouracil (50 mg/mL) in 1:1 ratio, administered monthly for 3 courses 3
- Polarized light therapy (400-3400 nm) performed the day after each injection session 3
This multimodal approach achieved complete resolution with no recurrence at 9-month follow-up in recurrent cases 3.
Adjuvant Radiation Therapy
Postoperative brachytherapy demonstrates the lowest recurrence rates (3.1-15%) among all treatment modalities 4, significantly outperforming external beam radiotherapy (14-29.3%) 4.
When to use brachytherapy:
- Recurrent keloids with prior treatment failures
- Keloids on the thorax (highest recurrence risk location) 5
- Craniofacial keloids where targeted radiation minimizes exposure to critical structures 6
Apply brachytherapy at wound margins where keloids most commonly recur, typically within the early postoperative period 6.
Location-Specific Considerations
Thoracic keloids require aggressive monitoring and treatment - multivariable analysis identified thorax location as the only significant independent risk factor for recurrence 5. These lesions warrant consideration of combined surgery plus radiotherapy as first-line treatment.
Auricular keloids: Individualized surgical approach based on keloid size and invasion depth, followed by postoperative triamcinolone injections. Compression therapy can be added, achieving recurrence rates of 10.66-14% 4.
Critical Technical Points
Surgical technique matters:
- Use tension-adapted sutures in layered closure to minimize mechanical stress 3
- Complete excision of the keloid core, not just superficial debulking 2
- Consider scar flap repair techniques for complex anatomical locations 2
Common pitfall: Inadequate postoperative injection compliance leads to recurrence. One study reported recurrence in a patient who failed to receive regular postoperative injections 2. Ensure patient commitment to the full injection protocol before proceeding with surgery.
Monotherapy Limitations
Avoid monotherapy for recurrent keloids - surgical excision alone carries prohibitively high recurrence rates. Triamcinolone monotherapy shows variable recurrence (6.6-33%) depending on protocol 4. Recurrent keloids are more aggressive than primary lesions and require multimodal treatment 2.
Treatment Selection Framework
Choose based on keloid characteristics:
- Small, accessible recurrent keloid: Surgery + postoperative triamcinolone injections 2, 1
- Large or multiple recurrent keloids: Surgery + triamcinolone/5-FU combination + polarized light therapy 3
- Thoracic location or multiple prior recurrences: Surgery + postoperative brachytherapy 5, 4, 6
- Auricular keloids: Excision with morphology reconstruction + postoperative triamcinolone + compression therapy 2, 4
Expected Outcomes
With appropriate multimodal treatment, recurrence rates can be reduced to 3.1-15% with brachytherapy 4, or achieve complete resolution with triple therapy (surgery + injections + light therapy) 3. Patient and Observer Scar Assessment Scale scores improve significantly with combined approaches 5, 2.
Follow-up schedule: Monitor at 1,3,6 months, and 1 year post-treatment to detect early recurrence 5.